Gebauer Company
APMA News Brief
Facebook Twitter LinkedIn YouTube
August 27, 2020 In This Issue
National News
What PATIENTS Are Reading
National News
The Supreme Court is scheduled to hear a arguments on the legality of the Affordable Care Act on November 10. 
 
Editor's note: Visit APMA's health-care reform page to learn more about key provisions in the ACA for podiatrists and more.
 
Recent data shows that patient revenue remains at a lower level than last year, even after a majority of states re-opened.
 
Editor's note: The deadline to apply for the Medicaid/CHIP provider relief fund tranche is now August 28! APMA has teamed up with Bankers Healthcare Group to offer mem​bers cash flow without the hassle Learn more about financial assistance for practices during COVID-19.
 
EpiFix® Dehydrated Human Amnion/Chorion Membrane Allograft
MiMedx Group Inc.
Intended for homologous use in the treatment acute and chronic wounds, EpiFix allografts may be stored at ambient conditions for up to 5 years and are available in a variety of sizes. Explore the use of EpiFix® in your wound treatment applications.
Learn more
Advertisement
Following up on claims denials effectively requires a solid plan.
 
A new two-minute self-assessment tool has been developed to help ascertain a physician's state of well-being.
 
​Editor's note: Feeling overwhelmed? Visit www.apma.org/wellbeing for help.
 
The Tetra Corporation
Kybun USA
DERMACLOSE YOUR NEXT CASE
Synovis Micro Companies Alliance
The DERMACLOSE Continuous External Tissue Expander device facilitates rapid tissue movement to reduce or reapproximate wounds. After the initial application has been completed the DERMACLOSE device does not require any additional tightening. Once the desired tissue expansion has occurred the device(s) can be removed and the wound can be closed with suture or staples.
Click Here to Read More
Advertisement
Some practices have discovered ways to maintain a team-based approach when using virtual care.
 
Business planning issues to consider include formally documenting ownership as well as roles and expectations.
 
Editor’s note: Take advantage of APMA’s practice management and reimbursement resources.
 
What Patients are Reading
A number of factors play a role in the development of painful bone spurs.
 
Activities such as diving into a vigorous exercise routine without preparation and spending a lot of time barefoot at home can lead to heel pain.
 
Among the tips for beginning hikers is choosing protective footwear with good traction.
 
Simplify, Automate & Grow Your Business
Power Diary®
Power Diary’s clinic-management tools and features will make running a health practice easier and provide a fuss-free experience for the patient.
Start a free trial today!
Advertisement
A recent global survey of health-providers suggests that the pandemic has had an effect on a number of elements of patient care.
 
Investigations continue regarding the possible effect of postal service changes on the delivery of medications by mail.
 
Ortho-Dynamics Orthotic Laboratory
Since our inception in 1990, Ortho-Dynamics has been committed to engineering the highest quality custom orthotics and foot & ankle braces. Our motto says it all: "Leadership in Foot Care Technology... Partnership in Foot Care!"
Advertisement
Cadence Insoles
Free Trial!  Sold in Podiatry clinics across the country, Cadence provide varying degrees of semi-rigid support with enhanced shock absorbing comfort under the heel and forefoot.  Exclusive models available.  Call or email for a free pair. 805-458-0567
Advertisement
 
Disclaimer: Stories from sources other than APMA do not necessarily reflect APMA positions or policies. APMA does not endorse these stories. This content appears in the News Brief to enhance members' understanding of how media coverage shapes perceptions of podiatric medicine, and to educate members about what their patients, legislators and other healthcare professionals are seeing in the media.
 

 

Advertise

We would appreciate your comments or suggestions.
Your email will be kept private and confidential.